Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-12 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-25 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ATOS | Atossa Therapeutics | 2.23 | 0.09 | 4.21% | 159.6M |
You can purchase shares of Atossa Therapeutics (NASDAQ: ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Celcuity (NASDAQ:CELC), DiaMedica Therapeutics (NASDAQ:DMAC) and GlycoMimetics (NASDAQ:GLYC).
The latest price target for Atossa Therapeutics (NASDAQ: ATOS) was reported by Ascendiant Capital on 2020-09-17. The analyst firm set a price target for 7.00 expecting ATOS to rise to within 12 months (a possible 213.90% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $2.23 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Atossa Therapeutics.
There is no upcoming split for Atossa Therapeutics.